TRANSITION, SEPARATION AND RELEASE OF CLAIMS AGREEMENTTransition, Separation and Release of Claims Agreement • May 30th, 2019 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This Transition, Separation and Release of Claims Agreement (the “Agreement”) is made as of the Agreement Effective Date (as defined below) by and between Ocular Therapeutix, Inc. (the “Company”) and Dr. Amarpreet S. Sawhney (“Executive”) (together, the “Parties”).
OCULAR THERAPEUTIX, INC. CONSULTING AGREEMENTConsulting Agreement • May 30th, 2019 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (this “Agreement”) is entered into as of May 29, 2019 by and between Ocular Therapeutix, Inc. (the “Company”), and Dr. Amarpreet S. Sawhney (the “Consultant”), and will be effective as of the day immediately following the Separation Date (hereinafter, the “Consulting Effective Date”). Capitalized terms used but not defined herein have the meanings set forth in the Transition, Separation and Release of Claims Agreement entered into by the Company and the Consultant (the “Separation Agreement”) to which this Agreement is attached as Attachment A.
